A randomized phase ii trial investigating the effect of platelet function inhibition on circulating tumor cells in patients with metastatic breast cancer

Clinical Breast Cancer

Volumn 13, Issue 6, 2013, Pages 409-415

  Roop, Ryan P ^a   Naughton, Michael J ^a   Van Poznak, Catherine ^b   Schneider, Jochen G ^c   Lammers, Philip E ^d   Pluard, Timothy J ^a   Johnson, Farley ^e   Eby, Charles S ^a   Weilbaecher, Katherine N ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c SAARLAND UNIVERSITY   (Germany)

^d VANDERBILT UNIVERSITY   (United States)

^e USA   (United States)

Author keywords

Breast cancer; Circulating tumor cells; Platelet inhibitors

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; THROMBIN;

ADULT; ARTICLE; BLEEDING; BREAST METASTASIS; CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER GROWTH; CANCER SURVIVAL; CIRCULATING TUMOR CELL; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; EDEMA; FEMALE; HUMAN; LOADING DRUG DOSE; LYMPHOCYTOPENIA; MUCOSA INFLAMMATION; NAUSEA; OUTCOME ASSESSMENT; PHASE 2 CLINICAL TRIAL; PHLEBOTOMY; RANDOMIZED CONTROLLED TRIAL; SKIN BRUISING; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION;

BREAST CANCER; CIRCULATING TUMOR CELLS; PLATELET INHIBITORS;

ASPIRIN; BLOOD PLATELETS; BREAST NEOPLASMS; CASE-CONTROL STUDIES; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASTIC CELLS, CIRCULATING; PLATELET ACTIVATION; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PROGNOSIS; TICLOPIDINE; TREATMENT OUTCOME;

EID: 84889069063     PISSN: 15268209     EISSN: 19380666     Source Type: Journal    
DOI: 10.1016/j.clbc.2013.08.006     Document Type: Article

References (30)

1. I. Gouin-Thibault, A. Achkar, and M.M. Samama The thrombophilic state in cancer patients Acta Haematol 106 2001 33 42
2. T. Wun, and R.H. White Venous thromboembolism (VTE) in patients with cancer: epidemiology and risk factors Cancer Invest 27 suppl 1 2009 63 74
3. A.K. Kakkar, and M.N. Levine Thrombosis and cancer: implications beyond Trousseau J Thromb Haemost 2 2004 1261 1262
4. J.S. Palumbo, K.E. Talmage, and J.V. Massari Tumor cell-associated tissue factor and circulating hemostatic factors cooperate to increase metastatic potential through natural killer cell-dependent and-independent mechanisms Blood 110 2007 133 141
5. G.J. Gasic, T.B. Gasic, and C.C. Stewart Antimetastatic effects associated with platelet reduction Proc Natl Acad Sci U S A 61 1968 46 52
6. S. Karpatkin, E. Pearlstein, and C. Ambrogio Role of adhesive proteins in platelet tumor interaction in vitro and metastasis formation in vivo J Clin Invest 81 1988 1012 1019
7. J.L. Francis, and A. Amirkhosravi Effect of antihemostatic agents on experimental tumor dissemination Semin Thromb Hemost 28 2002 29 38
8. E. Pearlstein, C. Ambrogio, and S. Karpatkin Effect of antiplatelet antibody on the development of pulmonary metastases following injection of CT26 colon adenocarcinoma, Lewis lung carcinoma, and B16 amelanotic melanoma tumor cells into mice Cancer Res 44 1984 3884 3887
9. B.A. Kerr, N.P. McCabe, and W. Feng Platelets govern pre-metastatic tumor communication to bone Oncogene 32 2013 4319 4324
10. L. Hu, M. Lee, and W. Campbell Role of endogenous thrombin in tumor implantation, seeding, and spontaneous metastasis Blood 104 2004 2746 2751
11. F.R. Rickles, S. Patierno, and P.M. Fernandez Tissue factor, thrombin, and cancer Chest 124 3 suppl 2003 58S 68S
12. M.L. Nierodzik, A. Plotkin, and F. Kajumo Thrombin stimulates tumor-platelet adhesion in vitro and metastasis in vivo J Clin Invest 87 1991 229 236
13. S. Karpatkin Role of thrombin in tumor angiogenesis, implantation, and metastasis Pathophysiol Haemost Thromb 33 suppl 1 2003 54 55
14. W. Ochmanski Influence of antiplatelet drugs (AD) on the efectiveness of combined therapy of small cell lung cancer. Part II. Influence of treatment on time of remission and patients survival [Article in Polish] Przegl Lek 65 2008 321 328
15. M. Cristofanilli, G.T. Budd, and M.J. Ellis Circulating tumor cells, disease progression, and survival in metastatic breast cancer N Engl J Med 351 2004 781 791
16. W.J. Allard, J. Matera, and M.C. Miller Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases Clin Cancer Res 10 2004 6897 6904
17. A.D. Michelson, A.L. Frelinger 3rd, and M.I. Furman Current options in platelet function testing Am J Cardiol 98 2006 4N 10N
18. H.C. Hemker, P. Giesen, and R. Al Dieri Calibrated automated thrombin generation measurement in clotting plasma Pathophysiol Haemost Thromb 33 2003 4 15
19. F.C. Bidard, D. Hajage, and T. Bachelot Assessment of circulating tumor cells and serum markers for progression-free survival prediction in metastatic breast cancer: a prospective observational study Breast Cancer Res 14 2012 R29
20. A. Lucci, C.S. Hall, and A.K. Lodhi Circulating tumour cells in non-metastatic breast cancer: a prospective study Lancet Oncol 13 2012 688 695
21. B. Franken, M.R. de Groot, and W.J. Mastboom Circulating tumor cells, disease recurrence and survival in newly diagnosed breast cancer Breast Cancer Res 14 2012 R133
22. S.J. Bakewell, P. Nestor, and S. Prasad Platelet and osteoclast beta3 integrins are critical for bone metastasis Proc Natl Acad Sci U S A 100 2003 14205 14210
23. O. Engebraaten, M. Trikha, and S. Juell Inhibition of in vivo tumour growth by the blocking of host alpha(v)beta3 and alphaII(b)beta3 integrins Anticancer Res 29 2009 131 137
24. O. Uluckan, M.C. Eagleton, and D.H. Floyd APT102, a novel adpase, cooperates with aspirin to disrupt bone metastasis in mice J Cell Biochem 104 2008 1311 1323
25. C. Bosetti, S. Gallus, and C. La Vecchia Aspirin and cancer risk: a summary review to 2007 Recent Results Cancer Res 181 2009 231 251
26. P.H. Gann, J.E. Manson, and R.J. Glynn Low-dose aspirin and incidence of colorectal tumors in a randomized trial J Natl Cancer Inst 85 1993 1220 1224
27. N.R. Cook, I.M. Lee, and J.M. Gaziano Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial JAMA 294 2005 47 55
28. E. Flossmann, and P.M. Rothwell Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies Lancet 369 2007 1603 1613
29. A. Lipton, S. Scialla, and H. Harvey Adjuvant antiplatelet therapy with aspirin in colo-rectal cancer J Med 13 1982 419 429
30. U. Nieminen, A. Kauppila, and M. Gronroos Placebo-controlled study on the efficacy of the pyrimido-pyrimidine derivative RA 233 in ovarian cancer Gynecol Oncol 36 1990 226 231